Influence of hemolysis, lipemia and bilirubin on biobank sample quality- origin and interference in the use for extracellular vesicle (EV) and MiRNA analyses.

Birte Weber, Wolfgang Welz, Inna Schaible, Jiaoyan Han, Dirk Henrich, Ingo Marzi, Liudmila Leppik
Author Information
  1. Birte Weber: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany. bi.weber@med.uni-frankfurt.de.
  2. Wolfgang Welz: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
  3. Inna Schaible: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
  4. Jiaoyan Han: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
  5. Dirk Henrich: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
  6. Ingo Marzi: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
  7. Liudmila Leppik: Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.

Abstract

PURPOSE: Pre-analytic interferences can influence the laboratory downstream measurements. We recognized hemolysis, lipemia and bilirubin in some of the serum/plasma samples of the NTF-Biobank from polytraumatized patients. Aim of the present study was to detect interferences, find reasons and describe the influence on downstream analyses.
METHODS: The study included serum samples of n = 88 polytraumatized patients admitted to a Level 1 Trauma Center in Germany at the ER & up to 10 days after trauma. Optical absorption spectra of UV-VIS (350-660 nm) were measured to detect hemolysis, lipemia and bilirubin. To find reasons for the interferences, clinical parameters like triglycerides (TAGs), nutrition, anaesthesia or transfusions were collected from patients' record. Extracellular vesicles (EVs) were isolated by SEC from controls, lipidemic and hemolytic samples and analysed via NTA.
RESULTS: Within 10 days after trauma 31.8% of polytraumatized patients' samples showed hemolysis, 12.5% showed increased bilirubin and 15.9% lipemia. Hemolysis occurred in samples mostly at the ER (18%) and was not associated with the number of red blood cell transfusions or the ISS. Both contaminants, hemolysis and lipemia interfered with EV/EV-miRNA measurements. EV miR-16-5p was significantly increased in patients with hemolysis. The presence of lipids further influenced the EV particle size distribution and concentration.
CONCLUSION: The optical absorption spectra measurement is an easy tool for a robust pre-analytic sample controlling for the presence of interferences. Nutrition and anaesthesia were found to be related with lipemia in samples. Hemolysis and lipemia interfered with EV/EV-miRNA analysis. Therefore, the optical absorption spectra pre-analyses should be incorporated in the EV-biobank sampling.

Keywords

References

  1. Stroke. 2003 Dec;34(12):2796-800 [PMID: 14657544]
  2. Eur J Trauma Emerg Surg. 2020 Jun;46(3):499-504 [PMID: 31324937]
  3. Acad Pathol. 2019 Nov 22;6:2374289519888754 [PMID: 31803827]
  4. Int J Lab Hematol. 2020 Feb;42(1):88-94 [PMID: 31846202]
  5. BMJ Mil Health. 2025 Mar 21;171(2):173-178 [PMID: 37236652]
  6. J Extracell Vesicles. 2024 Feb;13(2):e12404 [PMID: 38326288]
  7. Crit Care Res Pract. 2014;2014:346968 [PMID: 25580289]
  8. Minerva Chir. 1997 Apr;52(4):485-7 [PMID: 9265136]
  9. Front Immunol. 2023 Mar 09;14:1107150 [PMID: 36969201]
  10. Front Genet. 2019 May 22;10:463 [PMID: 31191602]
  11. Ann Clin Biochem. 2016 Sep;53(Pt 5):527-38 [PMID: 27147624]
  12. Clin Biochem. 2017 Dec;50(18):1317-1322 [PMID: 28947321]
  13. Anal Bioanal Chem. 2020 Feb;412(4):805-810 [PMID: 31858169]
  14. Transfus Med. 2018 Aug;28(4):319-325 [PMID: 29460456]
  15. Biochem Med (Zagreb). 2014 Feb 15;24(1):57-67 [PMID: 24627715]
  16. Expert Opin Drug Deliv. 2013 Nov;10(11):1533-49 [PMID: 23919912]
  17. Ann Am Thorac Soc. 2023 Jan;20(1):94-101 [PMID: 36053664]
  18. J Clin Med. 2023 Jun 21;12(13): [PMID: 37445238]
  19. Int J Mol Sci. 2023 Jul 23;24(14): [PMID: 37511589]
  20. Intensive Care Med. 2012 Dec;38(12):1990-8 [PMID: 23052949]
  21. J Clin Nurs. 2021 Jul;30(13-14):1916-1926 [PMID: 33829557]
  22. PLoS One. 2021 Aug 5;16(8):e0255230 [PMID: 34351969]
  23. Cardiovasc Diabetol. 2024 Oct 17;23(1):368 [PMID: 39420340]
  24. Clin Chim Acta. 2015 Jan 1;438:241-5 [PMID: 25128720]
  25. BMC Vet Res. 2022 Sep 22;18(1):355 [PMID: 36138476]
  26. Oncol Lett. 2017 Jan;13(1):315-320 [PMID: 28123561]
  27. Shock. 2023 Jan 1;59(1):12-19 [PMID: 36378232]
  28. Clin Chem Lab Med. 2023 Jan 13;61(6):1035-1045 [PMID: 36635939]
  29. PLoS One. 2011;6(9):e24145 [PMID: 21909417]
  30. Medicine (Baltimore). 2020 Jul 2;99(27):e21020 [PMID: 32629724]
  31. PLoS One. 2015 Nov 25;10(11):e0143527 [PMID: 26606144]
  32. Clin Chem Lab Med. 2009;47(8):940-4 [PMID: 19589105]
  33. Eur J Trauma Emerg Surg. 2022 Jun;48(3):1525-1544 [PMID: 33533957]
  34. Nat Commun. 2022 Nov 10;13(1):6789 [PMID: 36357394]
  35. Clin Chem Lab Med. 2008;46(6):764-72 [PMID: 18601596]
  36. Sci Rep. 2016 Apr 18;6:24316 [PMID: 27087061]

MeSH Term

Humans
Hemolysis
Bilirubin
Extracellular Vesicles
MicroRNAs
Male
Female
Hyperlipidemias
Middle Aged
Adult
Multiple Trauma
Germany
Biological Specimen Banks
Aged

Chemicals

Bilirubin
MicroRNAs

Word Cloud

Created with Highcharts 10.0.0lipemiahemolysissamplesinterferencesbilirubinpolytraumatizedpatientsabsorptionspectraEVinfluencedownstreammeasurementsstudydetectfindreasonsanalysesER10daystraumaanaesthesiatransfusionspatients'showedincreasedHemolysisinterferedEV/EV-miRNApresenceopticalsampleNutritionPURPOSE:Pre-analyticcanlaboratoryrecognizedserum/plasmaNTF-BiobankAimpresentdescribeMETHODS:includedserumn = 88admittedLevel1TraumaCenterGermany&OpticalUV-VIS350-660 nmmeasuredclinicalparametersliketriglyceridesTAGsnutritioncollectedrecordExtracellularvesiclesEVsisolatedSECcontrolslipidemichemolyticanalysedviaNTARESULTS:Within318%125%159%occurredmostly18%associatednumberredbloodcellISScontaminantsmiR-16-5psignificantlylipidsinfluencedparticlesizedistributionconcentrationCONCLUSION:measurementeasytoolrobustpre-analyticcontrollingfoundrelatedanalysisThereforepre-analysesincorporatedEV-biobanksamplingInfluencebiobankquality-origininterferenceuseextracellularvesicleMiRNABiobankExosomesHyperbilirubinemiaPOCTPropofol

Similar Articles

Cited By